Dr. Mark Nestor, MD, Medical Director & President of South Beach Symposium and President of the American Cutaneous Oncology Society (ACOS), recently interviewed Sensus Healthcare’s CEO, Joe Sardano. The interview occurred last week as a virtual lead-in to February’s Symposium. In it, Mr. Sardano discusses the treatment of non-melanoma skin cancer patients with SRT during the COVID-19 pandemic, the prospect of increased reimbursement for SRT and the opportunities provided and plans for growth with the company’s newly acquired mobile laser business.
